A. Pocoví

Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

D. Antoniucci, Alfredo E. Rodríguez, C. Fernandez-Pereira, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Revascularization strategies for patients with multiple vessel coronary disease and unprotected left main. A prospective, multicenter and controlled Argentina registry with a cobalt-chromium rapamycin eluting stent, FIREBIRD 2™: protocol design and methods of the ERACI IV Registry

D. Antoniucci, Alfredo E. Rodríguez, C. Fernandez-Pereira, 2014 .

Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.

I. Palacios, G. Stone, J. Granada, 2006, Journal of the American College of Cardiology.

Carotid angioplasty is an alternative therapeutic option to carotid endarterectomy for a defined group of patients

A. Pocoví, 2012 .

ral Rapamycin After Coronary are-Metal Stent Implantation to Prevent Restenosis

J. Granada, Juan A. Delgado, A. Raizner, 2006 .

Acute Rupture of an Aortic False Aneurysm Treated with a Stent-Graft

J. Parodi, C. Schönholz, A. Pocoví, 1999, Journal of endovascular surgery : the official journal of the International Society for Endovascular Surgery.

Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial)

J. Ambrose, C. Pereira, M. Rodríguez Alemparte, 2005, Heart.

State of the art for the revascularization treatment of the extra craneal internal carotid artery. Carotid angioplasty role in light of randomized trials

A. Pocoví, 2012 .